EQ/International Equity Index Portfolio

EQ Advisors Trust

Developed international equity index fund
$2.29B NAV
699 positions · as of 2026-06-30 · filed 2026-08-25

Fund classification

Classified from what the fund holds · as of 2026 Q2

EQ/International Equity Index Portfolio is a developed international equity index fund.

Asset class
Equity
Region
Developed international
Management
Index (passive)
Fund type
Open-end fund

Fund profile

As filed in the prospectus · 2025 Q2

Seeks to achieve a total return (before expenses) that approximates the total return performance of a composite index comprised of 40% DJ Euro-STOXX 50 Index, 25% FTSE 100 Index, 25% TOPIX Index, and 10% S&P/ASX 200 Index, including reinvestment of dividends, at a risk level consistent with that of the composite index.

Strategy · summarised

The fund tracks a composite index weighted 40% DJ EuroSTOXX 50, 25% FTSE 100, 25% TOPIX, and 10% S&P/ASX 200 through a sub-adviser that uses replication for the FTSE 100, EuroSTOXX 50, and S&P/ASX 200, though sampling may be employed in certain circumstances, while TOPIX holdings are selected through stratified sampling based on industry weightings, market capitalizations, and yields. Because the sub-adviser may sample rather than replicate the FTSE 100, EuroSTOXX 50, and S&P/ASX 200, and uses stratified sampling for TOPIX, the fund's returns may diverge from its composite benchmark.

Expenses
0.47% 0.72%across 3 share classes
Share classGrossNet
C0000245980.79%0.72%
C0000245990.79%0.72%
C0001041670.54%0.47%

Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.

Portfolio turnover 5.00% · as of 2025 Q2

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

99.77%
of net assets
Stocks98.41%
Cash & short-term1.37%
Other0.00%
Derivatives-0.01%

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Derivatives are shown at market value, not notional exposure.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 347 new847 exited

Largest new: Roche Holding AG, Novartis AG, Nestle SA, ABB Ltd., UBS Group AG, Novo Nordisk A/S, Cie Financiere Richemont SA, Zurich Insurance Group AG

Largest exited: Scottish Mortgage Investment Trust plc, Toyota Industries Corp., Diploma plc, Beazley plc, Weir Group plc (The), ResMed, Inc., IMI plc, St James's Place plc

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+25.23%
3-year
+55.31%
5-year
+58.32%
Volatility
14.34%
Worst 3-yr fall
-10.63%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
ASML Holding NV3.50%$80.21M
HSBC Holdings plc1.49%$34.01M
Roche Holding AG1.32%$30.13M
Novartis AG1.31%$29.88M
AstraZeneca plc1.29%$29.48M
Nestle SA1.21%$27.57M
Siemens AG1.09%$24.87M
Shell plc0.99%$22.66M
Tokyo Electron Ltd.0.99%$22.58M
BHP Group Ltd.0.97%$22.10M
Showing 10 of 699Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 14.14% of net assets, top 25 25.77%, across 689 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free